【レポートの概要（一部）】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Antibiotics Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users, by region / by product / by country
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.2. Development of advanced products
3.7.3. Increasing prevalence of` infectious diseases
3.7.4. Rising collaborative development efforts
3.7.5. Market Restraint Analysis
3.7.6. Uncertain regulatory policies
3.7.7. High R & D cost
3.7.8. Development of resistance against antibiotics
3.7.9. Industry Challenges
3.7.10. Increasing resistance to antibiotics.
3.8. Antibiotics: Market Analysis Tools
3.8.1. Industry Analysis – Porter’s
3.8.1.1. Supplier Power: (Low)
3.8.1.2. Buyer Power: (Moderate)
3.8.1.3. Substitution Threat: (Moderate)
3.8.1.4. Threat from new entrant: (Moderate)
3.8.1.5. Competitive rivalry: (High)
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
Chapter 4. Antibiotics Market: Segment Analysis, By Action Mechanism, 2015 – 2026 (USD Million)
4.1. Definitions & Scope
4.2. Action mechanism market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Antibiotics Market, by Action Mechanism, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Cell Wall Synthesis Inhibitors
4.5.2. Protein Synthesis Inhibitors
4.5.3. DNA Synthesis Inhibitors
4.5.4. RNA Synthesis Inhibitors
4.5.5. Mycolic Acid Inhibitors
Chapter 5. Antibiotics Market: Segment Analysis, By Drug Class, 2015 – 2026 (USD Million)
5.1. Definitions & Scope
5.2. Action mechanism market share analysis, 2018 & 2026
5.3. Segment Dashboard
5.4. Global Antibiotics Market, by Drug Class, 2015 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
5.5.1. Cephalosporin
5.5.2. Penicillin
5.5.3. Fluoroquinolones
5.5.4. Macrolides
5.5.5. Carbapenem
5.5.6. Aminoglycosides
5.5.7. Sulfonamides
5.5.8. Other
Chapter 6. Antibiotics Market: Regional Market Analysis, 2015 – 2026 (USD Million)
6.1. Definitions & Scope
6.2. Regional market share analysis, 2018 & 2026
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
6.5. Regional Market Share and Leading Players, 2018
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East & Africa
6.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
6.6.1. North America
6.6.2. Europe
6.6.3. Asia Pacific
6.6.4. Latin America
6.6.5. Middle East & Africa
6.7. Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:
6.8. North America
6.8.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
6.8.2. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.8.3. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.8.4. U.S.
6.8.4.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.8.4.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.8.5. Canada
6.8.5.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.8.5.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9. Europe
6.9.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
6.9.2. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.3. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9.4. Germany
6.9.4.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.4.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9.5. U.K.
6.9.5.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.5.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9.6. France
6.9.6.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.6.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9.7. Italy
6.9.7.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.7.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9.8. Spain
6.9.8.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.8.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10. Asia Pacific
6.10.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
6.10.1.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.1.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10.2. China
6.10.2.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.2.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10.3. Japan
6.10.3.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.3.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10.4. India
6.10.4.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.4.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10.5. Thailand
6.10.5.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.5.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10.6. South Korea
6.10.6.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.6.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.11. Latin America
6.11.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
6.11.2. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.11.3. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.11.4. Brazil
6.11.4.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.11.4.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.11.5. Mexico
6.11.5.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.11.5.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.11.6. Argentina
6.11.6.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.11.6.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.11.7. Columbia
6.11.7.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.11.7.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.12. Middle East and Africa
6.12.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
6.12.2. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.12.3. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.12.4. South Africa
6.12.4.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.12.4.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.12.5. Saudi Arabia
6.12.5.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.12.5.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.12.6. UAE
6.12.6.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.12.6.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
Chapter 7. Antibiotics Market – Competitive Analysis
7.1. Recent developments & impact analysis, by key market participants
7.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2018
7.4. Public Companies
7.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
7.4.2. Company Market Share/Ranking, by region
7.4.3. Competitive Dashboard Analysis
7.4.3.1. Market Differentiators
7.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
7.5. Private Companies
7.5.1. List of key emerging companies’ /technology disruptors/innovators
7.5.2. Funding Outlook (Optional)
7.5.3. Regional network map
7.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
7.6. Supplier Ranking
7.7. Key companies profiled
7.7.1. Pfizer, Inc.
7.7.1.1. Company Overview
7.7.1.2. Financial Performance
7.7.1.3. Product Benchmarking
7.7.1.4. Strategic Initiatives
7.7.2. Janssen Pharmaceuticals.
7.7.2.1. Company Overview
7.7.2.2. Financial Performance
7.7.2.3. Product Benchmarking
7.7.2.4. Strategic Initiatives
7.7.3. Abbott
7.7.3.1. Company Overview
7.7.3.2. Financial Performance
7.7.3.3. Product Benchmarking
7.7.3.4. Strategic Initiatives
7.7.4. GlaxoSmithKline plc.
7.7.4.1. Company Overview
7.7.4.2. Financial Performance
7.7.4.3. Product Benchmarking
7.7.4.4. Strategic Initiatives
7.7.5. Sanofi.
7.7.5.1. Company Overview
7.7.5.2. Financial Performance
7.7.5.3. Product Benchmarking
7.7.5.4. Strategic Initiatives
7.7.6. Novartis AG.
7.7.6.1. Company Overview
7.7.6.2. Financial Performance
7.7.6.3. Product Benchmarking
7.7.6.4. Strategic Initiatives
7.7.7. Bayer AG.
7.7.7.1. Company Overview
7.7.7.2. Financial Performance
7.7.7.3. Product Benchmarking
7.7.7.4. Strategic Initiatives
7.7.8. Bristol-Myers Squibb Company.
7.7.8.1. Company Overview
7.7.8.2. Financial Performance
7.7.8.3. Product Benchmarking
7.7.8.4. Strategic Initiatives
7.7.9. Eli Lilly and Company.
7.7.9.1. Company Overview
7.7.9.2. Financial Performance
7.7.9.3. Product Benchmarking
7.7.9.4. Strategic Initiatives
7.7.10. Astellas Pharma, Inc.
7.7.10.1. Company Overview
7.7.10.2. Financial Performance
7.7.10.3. Product Benchmarking
7.7.10.4. Strategic Initiatives
Chapter 8. KOL Commentary
Chapter 9. Recommendations
【レポート販売概要】
■ タイトル：抗生物質の世界市場：作用機序別（タンパク質、DNA、RNA、細胞壁合成阻害剤）、薬剤クラス別（ペニシリン、セファロスポリン、フルオロキノロン）、セグメント予測■ 英文：Antibiotics Market Size, Share & Trends Analysis Report By Action Mechanism (Protein, DNA, RNA, Cell Wall Synthesis Inhibitors), By Drug Class (Penicillin, Cephalosporins, Fluoroquinolones), And Segment Forecasts, 2019 - 2026
■ 発行日：2019年2月12日
■ 調査会社：Grand View Research
■ 商品コード：GVW903017
■ 調査対象地域：グローバル
- 通信分野電化製品のトレンド及び予測2011-2018（Telecommunication Electronics – Global Trends, Estimates and Forecasts, 2011-2018）Global Market Watch: With a CAGR of 12.8%, global market value for Telecommunication Electronics Application sector is anticipated to be worth US$847.6 billion by 2018. On a global scale, Asia-Pacific accounts for more than 26.3% of the market share. While US accounts for the largest share of the global market value on a country basis, India surpasses the US in terms of growth rate anticipated in …
- 電気絶縁材料の世界市場：熱可塑性物質、エポキシ樹脂、セラミックThe electrical insulation materials market is projected to reach USD 9.58 Billion by 2021 at CAGR of 5.82% from 2016. The rising demand for energy has increased the electrical and power transmission and distribution (T&D) activities which has also led to the increased use of electrical insulation materials. The market based on type is segmented into different types of materials such as thermoplast …
- 鉄筋の世界市場2016-2020About Steel Rebars Rebars are used as tensile devices in reinforced concrete to give strength and hold the concrete in tension. Apart from strength, rebars are used to absorb energy, adapt to extreme conditions, and hold stress during natural disasters. The market is anticipated to grow at a rapid pace due to extensive construction activities in APAC. Non-residential constructions are the major en …
- Span Diagnostics Ltd.：市場シェア分析Span Diagnostics Ltd. Market Share Analysis Summary GlobalData’s new report, “Span Diagnostics Ltd. Market Share Analysis” provides in-depth information on Span Diagnostics Ltd.’s market position in the different medical equipment markets it operates in. The report provides Span Diagnostics Ltd. market share information in five key market categories – Clinical Chemistry, Haematology, Immuno Chemis …
- 物流の世界市場：2PL、3PL、4PLABSTRACTAbout Logistics Logistics involve delivering, controlling, and planning of physical flow of goods, information exchange from the producer to a market as to meet the customer demands and outsourcing services that specializes in handling functions, such as transportation, warehousing, and freight and forwarding. Global logistics is the outsourcing of various elements of logistics and distrib …
- 耐熱樹脂の世界市場予測（～2026）：種類別（エポキシ、シリコーン、アクリル、ポリエステル、 ポリエーテルスルホン、アルキド、ポリウレタン、フェノール類、ポリエーテルアミド）、用途別、地域別The global high temperature resin market is estimated to reach USD 4.88 Billion by 2026, at a CAGR of 4.44% from 2016 to 2026. The increasing demand for the high temperature resin as an alternative to mechanical fasteners in high end applications, growth in application areas, increasing demand for high temperature composite resins in railway and aerospace interior applications, and the increasing …
- Enteric Diseases in Spain 2014: Market Outlook and Emerging OpportunitiesAbout This ReportThis new 322-page report from Venture Planning Group presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals and Commercial/Priv …
- BRIC（ブラジル/ロシア/インド/中国）の十二指腸内視鏡市場（～2020）BRIC Duodenoscopes Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Duodenoscopes Market Outlook to 2020", provides key market data on the BRIC Duodenoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Duodenoscopes and Flexible Non-Video (Fibre) Duodenoscopes. The report als …
- Rex Energy Corporation：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Rex Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Rex Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 温度制御式パッケージングの世界市場予測（～2021年）：断熱シッパー、断熱コンテナ、冷却剤“Temperature controlled packaging solutions market is projected to grow at a CAGR of 9.7%” The temperature controlled packaging solutions market is projected to reach USD 11.82 billion by 2021, at a CAGR of 9.7% from 2016 to 2021. Growth in the pharmaceuticals industry is helping create a demand for temperature controlled packaging solutions. However stringent rules & regulations formulated by gov …
- 世界のリチウム電池用陽極材料市場2015The Global Lithium Battery Anode Materials Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Lithium Battery Anode Materials industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Lithium Battery Anode Materials market analysis is provided for the intern …
- 家電用ジェスチャー認識の世界市場2018-2022About gesture recognition for consumer electronic devices Gesture recognition technology analyses human motions through computer algorithms. This consists of generating gestures and capturing them using a camera. The software identifies the gesture and matches it with the database to perform the necessary action. Technavio’s analysts forecast the Global gesture recognition market for consumer elec …
- 婦人科手術用器具の世界市場予測（～2021年）：剪刀、鉗子、トロカール、膣鏡（SIMS、CUSCO）、持針器The gynecology surgical instruments market is expected to reach USD 2.44 Billion by 2021 from USD 1.73 Billion in 2016, at a CAGR of 7.1% from 2016 to 2021. The market is mainly driven by factors such as high incidence of gynecological diseases, increasing awareness programs, and rising government investments for providing advanced healthcare facilities & services, increasing disposable income in …
- 1,4ブタンジオール（BDO）の世界市場分析：用途別（テトラヒドロフラン（THF）、ポリブチレンテレフタレート（PBT）、ガンマブチロラクトン（GBL）、ポリウレタン（PU））、地域別（北アメリカ、ヨーロッパ、アジア太平洋、CSA、MEA）、セグメント予測、2014-2025The global 1,4 butanediol (BDO) market is projected to reach USD 12.6 billion by 2025, according to a new report by Grand View Research, Inc. Pioneers of bio-based technologies such as Geomatica and BioAmber have paved the path for sustainable BDO production from renewable feedstock, which has influenced consumption patterns in recent years. Companies are increasingly adopting good manufacturing p …
- Penn Virginia Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Penn Virginia Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Penn Virginia Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essentia …
